Phase I Oncology
A Phase 1/1b, Multicenter, Open-label, Dose-escalation and A Phase 1/1b, Multicenter, Open-label, Dose-escalation and Pharmacokinetics of ODC-IL2 Administered via Intravenous Infusion in Adult Patients with Advanced or Metastatic Solid Tumors
Overview
A Phase 1/1b, Multicenter, Open-label, Dose-escalation and A Phase 1/1b, Multicenter, Open-label, Dose-escalation and Pharmacokinetics of ODC-IL2 Administered via Intravenous Infusion in Adult Patients with Advanced or Metastatic Solid Tumors
Information coming soon.
Information coming soon.
Information coming soon.